The COVID-19 pandemic has forced companies to adapt quickly to thrive in the face of changing threats. Businesses have learned a lot about the value of remaining adaptable in the short-term, that is, throughout the pandemic. However, the pandemic has revealed a need for a longer-term approach to business that emphasizes resilience. “2020 was a wake-up call,” advises McKinsey. “To thrive in the coming decade, companies must develop resilience — the ability to withstand unpredictable threat or change and then emerge stronger.”

A Long-Term, Multifaceted Resilience Strategy is Needed

Resilience is part of a long game that looks beyond short-term earnings, McKinsey says. What’s more, they write…

Do you believe you are, or can be, a successful day trader, buying and selling stocks on a regular basis?

Do you believe that you, or anyone you know, can successfully time the market, going in and out of the market, and consistently make profits?

You can’t, or at least not on any consistent basis over any reasonable period.

That’s the message from the new edition of Charles Ellis’ investment classic, “Winning the Loser’s Game.” First published way back in 1985, this eighth edition updates the book’s central theses: that passive investing (indexing) outperforms active investing, that investment fees are…

Tech and healthcare are working together in the COVID-19 pandemic to benefit the greater good. That’s why CNBC has predicted that both industries, including biopharma and biotech, will make gains in 2021. COVID-19 has put biopharma in the limelight and big-name tech investors are moving in: for example, tech entrepreneur and Facebook co-founder Peter Thiel recently joined a $35.4 million Series B round for Peptilogics.

Biopharma has made strides in 2020 and is on track for even more milestones in 2021. Big data and machine learning have helped biopharma better understand biological systems and diseases, and have enabled drug discovery…

2020 was the largest funding year ever for digital health, primarily because COVID-19’s social distancing requirements necessitated a shift to digital health via telemedicine. According to Rock Health, the “stock market’s sharp recovery and pandemic-initiated policy and regulation changes that have enabled large competitive moves and commercialization activities.” Looking ahead to the ensuing years, new entrants to digital health, such as major tech players Amazon, Google, and Apple, will continue to disrupt the standard care delivery model by developing novel digital health solutions.

2019 saw six major IPOs: Livongo (LVGO), Change Healthcare (CHNG), Health Catalyst (HCAT), Phreesia (PHR), Progyny (PGNY)…

The pandemic has highlighted the macro-level challenges of the healthcare landscape — legal, regulatory, and economic obstacles and enablers. These were issues that existed before the pandemic, but as COVID-19 continues, the need to tackle these issues will only increase in relevance for health care systems, hospitals, and health care plans in order to best serve stakeholders.

According to Deloitte, healthcare spending is expected to rise by 5% annually from 2019–2023. Yet, there are several aspects of the industry that require reform in order to deal with the rising costs of health care, including the rising cost of health care…

August 19, 2020

With some hope on the horizon for the COVID-19 pandemic, with many vaccines and treatments in the works, markets are on fire. However, with elections looming, chatter of a second wave of COVID-19, and money being printed by the feds, is a pull-back bound to happen? As Forbes reports, Goldman Sachs has predicted a smaller effect on the economy in the present quarter (Q2) and has adjusted its GDP forecasts accordingly.

Economic indicators point to a rosier future for the global economy, particularly in terms of continued long-term growth. …

As computer processor and wireless communications technology continues to improve, the Internet of Things will continue to transform healthcare. The Internet of Medical Things, or IoMT for short, has enabled more powerful wireless devices which can improve the standard of care for patients with chronic diseases. With advances in the high-tech industry, medical devices have gotten smaller and implanting procedures have become less invasive, which has also fueled these smart devices’ ubiquity.

What Are the Benefits of Connected Medical Devices and How Do They Work?

Importantly, smartphone-connected wireless devices have the ability to help manage and track conditions remotely —…

What’s the Outlook for Biopharma in 2020?

COVID-19 put a damper on the international economy in the first three months of 2020. In fact, the first quarter of 2020 represented the worst quarter ever for the Dow Jones Industrial Average or DJIA, with a year-to-date loss of 23% and impacts seen in all 11 sectors of the economy.

However, analysts now believe the economy is making a v-shaped recovery, as the current year-to-date change of the DJIA stands at a loss of just 3.9%. …